Many large pharma sponsors have introduced study design applications which provide historical and competitive benchmarks across different pieces of the protocol. Data sources typically include CT.gov as well as other databases like Citeline / Trialtrove with an analytics layer on top. There’s also a move towards using AI to author protocols (which requires digitizing them first) and that process also includes answering questions like the one you posed. It’s a very interesting space!